Latest Breaking News On - Analyst recommendations for xenon pharmaceuticals - Page 1 : comparemela.com

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the stock […]

Steven gannonSherrington robinXenon pharmaceuticals stock performanceCantor fitzgeraldFinancial services group incCapital partnersNews ratings for xenon pharmaceuticals dailyAnalyst recommendations for xenon pharmaceuticalsTower research capitalXenon pharmaceuticals incInsider activity at xenon pharmaceuticalsInstitutional trading of xenon pharmaceuticalsChina universal asset management coRoyal bankNeedham companyXenon pharmaceuticals